Financials
- Market Capitalization 942.6 M
- Employee 161
- Founded 2002
- CEO N/A
- Website www.dbv-technologies.com
- Headquarter France
- FIGI BBG0076D3T39
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-18.26
Fiyat/satışlar oranı
474.74
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2502 | JANX Janux Therapeutics, Inc. - Common Stock | 15.78 USD | -2.23% | -0.75% | +15.27% | -40.79% | 962.33 M USD | ||
| 2512 | SLDB Solid Biosciences Inc. - Common Stock | 9.63 USD | -0.93% | -11.33% | +32.46% | +68.95% | 948.07 M USD | ||
| 2519 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.12 USD | -2.30% | -9.40% | +8.72% | +78.15% | 941.70 M USD | ||
| 2520 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.42 USD | -2.40% | -7.45% | +2.05% | +28.79% | 941.66 M USD |